Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: Prognostic implications

Journal of the National Cancer Institute

Volumn 85, Issue 7, 1993, Pages 570-574

  Ciocca, Daniel R ^a   Clark, Gary M ^a   Tandon, Atul K ^a   Fuqua, Suzanne A W ^a   Welch, William J ^b   Mcguire, William L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE S PHASE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STRESS; TUMOR VOLUME;

ANALYSIS OF VARIANCE; AXILLA; BREAST NEOPLASMS; FEMALE; HEAT-SHOCK PROTEINS; HUMAN; LYMPHATIC METASTASIS; PROGNOSIS; RECURRENCE; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0027503365     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/85.7.570     Document Type: Article

References (31)

1. Carper SW, Duffy JJ, Gerner EW: Heat shock proteins in thermotolerance and other cellular processes. Cancer Res 47:5249-5255, 1987.
2. Lindquist S, Craig EA: The heat-shock proteins. Ann Rev Genet 22:631-677, 1988.
3. Morimoto RI: Heat shock: The role of transient inducible responses in cell damage, transformation, and differentiation. Cancer Cells 3:295-301, 1991.
4. Welch WJ, Feramisco JR: Rapid purification of mammalian 70,000-dalton stress proteins: Affinity of the proteins for nucleotides. Mol Cell Biol 5:1229-1237, 1985.
5. Ellis RJ: Molecular chaperones. Semin Cell Biol 1:1-9, 1990.
6. Hightower LE: Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66:191-197, 1991.
7. Kost SL, Smith DF, Sullivan WP, et al: Binding of heat shock proteins to the avian progesterone receptor. Mol Cell Biol 9:3829-3838, 1989.
8. Marguus BA, Welsh M: Analysis of protein binding to heat shock protein 70 in pancreatic islet cells exposed to elevated temperatures or interleukin l β. J Biol Chem 266:9295-9298, 1991.
9. Finlay CA, Hinds PW, Tan T-H, et al: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531-539, 1988.
10. Lehman TA, Bennett WP, Metcalf RA, et al: p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51:4090-4096, 1991.
11. Walter G, Carbone A, Welch WJ: Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein. J Virol 61:405-410, 1987.
12. Perdew GH, Whitelaw ML: Evidence that the 90-kDA heat shock protein (HSP90) exists in cytosol in heteromeric complexes containing HSP70 and three other proteins with Mr of 63,000, 56,000, and 50,000. J Biol Chem 266:6708-6713, 1991.
13. Li GC, Li L, Liu YK, et al: Thermal response of rat fibroblasts stably transfected with the human 70-kDa heat shock proteinencoding gene. Proc Natl Acad Sci USA 88:1681-1685, 1991.
14. Ciocca DR, Fuqua SA, Lock-Lim S, et al: Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52:3648-3654, 1992.
15. Velazquez JM, Lindquist S: hsp 70: Nuclear concentration during environmental stress and cytoplasmic storage during recovery. Cell 36:655-662, 1984.
16. Hatayama T, Tsukimi Y, Wakatsuki T, et al: Different induction of 70,000-Da heat shock protein and metallothionein in HeLa cells by copper. J Biochem 110:726-731, 1991.
17. Allred DC, Tandon AK, Clark GM, et al: Comprehensive evaluation of prognostic factors by immunocytochemistry on extremely small samples (50 mg) of “pulverized” breast carcinomas. Breast Cancer Res Treat 16:182(A149), 1990.
18. Tandon AK, Clark GM, Chamness GC, et al: HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7:1120-1128, 1989.
19. Smith PK, Krohn RI, Hermanson GT, et al: Measurement of protein using bi-cinchoninic acid. Anal Biochem 150:76-85, 1985.
20. Tandon AK, Clark GM, Chamness GC, et al: Cathepsin D and prognosis in breast cancer. N Engl J Med 322:297-302, 1990.
21. Riabowol KT, Mizzen LA, Welch WJ: Heat shock is lethal to fibroblasts microin-jected with antibodies against hsp70. Science 242:433-436, 1988.
22. McGuire WL, De La Garza M, Chamness GC: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37:637-639, 1977.
23. Powell B, Garola RE, Chamness GC, et al: Measurement of progesterone receptor in human breast cancer biopsies. Cancer Res 39:1678-1682, 1979.
24. Clark GM, Dressler LG, Owens MA, et al: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320:627-633, 1989.
25. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972.
26. SAS Institute Inc: SAS/STAT User’s Guide, version 6, 4th ed. Cary, NC: SAS Institute Inc, 1989.
27. Li G: Heat shock proteins: Role in thermotolerance, drug resistance, and relationship to DNA topoisomerases. Natl Cancer Inst Monogr 4:99-103, 1987.
28. Koskinen PJ, Sistonen L, Evan G, et al: Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc overexpressing cells. J Virol 65:842-851, 1991.
29. McGuire WL: Breast cancer prognostic factors: Evaluation guidelines. J Natl Cancer Inst 83:154-155, 1991.
30. McGuire WL, Tandon AK, Allred DC, et al: How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 82:1006-1015, 1990.
31. Kjmura E, Enns RE, Arboleda MJ, et al: Correlation of survival with mRNA expression of 60kD heat shock protein (hsp-60) in ovarian cancer patients. Proc ASCO 11:101, 1992.